JPY 170.0
(3.03%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 9.52 Billion JPY | 16.08% |
2022 | 8.2 Billion JPY | 36.69% |
2021 | 6 Billion JPY | 38.52% |
2020 | 4.33 Billion JPY | 22.09% |
2019 | 3.54 Billion JPY | 130.01% |
2018 | 1.54 Billion JPY | 66.99% |
2017 | 924 Million JPY | 48.52% |
2016 | 622.12 Million JPY | -96.96% |
2015 | 20.47 Billion JPY | -0.2% |
2014 | 20.51 Billion JPY | 4573.02% |
2013 | 438.94 Million JPY | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 9.48 Billion JPY | -0.38% |
2023 Q1 | 9.91 Billion JPY | 20.82% |
2023 FY | 9.52 Billion JPY | 16.08% |
2023 Q4 | 9.52 Billion JPY | 1.93% |
2023 Q2 | 9.54 Billion JPY | -3.74% |
2023 Q3 | 9.34 Billion JPY | -2.08% |
2022 Q4 | 8.2 Billion JPY | 8.29% |
2022 Q3 | 7.57 Billion JPY | 1.31% |
2022 Q2 | 7.47 Billion JPY | 11.11% |
2022 Q1 | 6.73 Billion JPY | 12.13% |
2022 FY | 8.2 Billion JPY | 36.69% |
2021 FY | 6 Billion JPY | 38.52% |
2021 Q3 | 5.95 Billion JPY | 16.73% |
2021 Q4 | 6 Billion JPY | 0.72% |
2021 Q1 | 4.27 Billion JPY | -1.25% |
2021 Q2 | 5.1 Billion JPY | 19.3% |
2020 Q1 | 3.33 Billion JPY | -6.09% |
2020 FY | 4.33 Billion JPY | 22.09% |
2020 Q4 | 4.33 Billion JPY | 5.07% |
2020 Q3 | 4.12 Billion JPY | 15.42% |
2020 Q2 | 3.57 Billion JPY | 7.2% |
2019 Q1 | 1.75 Billion JPY | 13.74% |
2019 Q4 | 3.54 Billion JPY | 15.23% |
2019 Q2 | 2.38 Billion JPY | 35.73% |
2019 Q3 | 3.08 Billion JPY | 29.3% |
2019 FY | 3.54 Billion JPY | 130.01% |
2018 Q3 | 1.32 Billion JPY | -6.56% |
2018 Q2 | 1.41 Billion JPY | 78.81% |
2018 Q1 | 793 Million JPY | -14.18% |
2018 FY | 1.54 Billion JPY | 66.99% |
2018 Q4 | 1.54 Billion JPY | 16.45% |
2017 Q4 | 924 Million JPY | 36.45% |
2017 FY | 924 Million JPY | 48.52% |
2017 Q1 | 601.63 Million JPY | -3.29% |
2017 Q2 | 558.8 Million JPY | -7.12% |
2017 Q3 | 677.18 Million JPY | 21.18% |
2016 FY | 622.12 Million JPY | -96.96% |
2016 Q3 | 623.13 Million JPY | 5.67% |
2016 Q4 | 622.12 Million JPY | -0.16% |
2016 Q2 | 589.68 Million JPY | 7.56% |
2016 Q1 | 548.24 Million JPY | -97.32% |
2015 FY | 20.47 Billion JPY | -0.2% |
2015 Q4 | 20.47 Billion JPY | -0.68% |
2015 Q3 | 20.6 Billion JPY | 0.08% |
2015 Q2 | 20.59 Billion JPY | 0.57% |
2015 Q1 | 20.47 Billion JPY | -0.17% |
2014 Q3 | 20.54 Billion JPY | 3612.9% |
2014 FY | 20.51 Billion JPY | 4573.02% |
2014 Q4 | 20.51 Billion JPY | -0.14% |
2014 Q1 | 412.84 Million JPY | -5.94% |
2014 Q2 | 553.22 Million JPY | 34.0% |
2013 FY | 438.94 Million JPY | 0.0% |
2013 Q4 | 438.94 Million JPY | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
DVx Inc. | 13.48 Billion JPY | 29.356% |
Seikagaku Corporation | 11.3 Billion JPY | 15.793% |
Eiken Chemical Co., Ltd. | 15.67 Billion JPY | 39.263% |
Create Medic Co., Ltd. | 4.31 Billion JPY | -120.725% |
PHC Holdings Corporation | 425.15 Billion JPY | 97.76% |
Techno Medica Co., Ltd. | 3.61 Billion JPY | -163.409% |
Rion Co., Ltd. | 8.2 Billion JPY | -16.101% |
Nihon Kohden Corporation | 52.14 Billion JPY | 81.739% |
Fukuda Denshi Co., Ltd. | 42.46 Billion JPY | 77.576% |
Japan Lifeline Co., Ltd. | 15.58 Billion JPY | 38.877% |
Japan Medical Dynamic Marketing, INC. | 5.88 Billion JPY | -61.899% |
3-D Matrix, Ltd. | 5.53 Billion JPY | -72.114% |